Have a personal or library account? Click to login

Effects of Interactions among Gene Polymorphisms of the Renin–Angiotensin-Aldosterone System on Hypertension in Turkish People from Southeast Anatolia

Open Access
|May 2019

References

  1. 1. Yamada Y, Matsuo H, Segawa T, Watanabe S, Kato K, Hibino T, et al. Assessment of the genetic component of hypertension. Am J Hypertens. 2006; 19(11):1158-65. DOI: 10.1016/j.amjhyper.2006.04.01010.1016/j.amjhyper.2006.04.01017070428
  2. 2. Tabassum N, Ahmad F. Role of natural herbs in the treatment of hypertension. Pharmacogn Rev. 2011; 5(9):30-40. DOI: 10.4103/0973-7847.7909710.4103/0973-7847.79097321000622096316
  3. 3. Bonfim-Silva R, GuimarAes LO, Souza Santos J, Perei-ra JF, Leal Barbosa AA, Souza Rios DL. Case-control association study of polymorphisms in the angioten-sinogen and angiotensin-converting enzyme genes and coronary artery disease and systemic artery hyperten-sion in African-Brazilians and Caucasian-Brazilians. J Genet. 2016; 95(1):63-9. DOI: 10.1007/s12041-015-0599-510.1007/s12041-015-0599-527019433
  4. 4. Kizilirmak P, Uresin AY. Hypertension and valsartan. Anadolu Kardiyol Derg. 2014; 14 Suppl 2:S20-4. DOI: 10.5152/akd.2014.0000410.5152/akd.2014.0000425604204
  5. 5. Siddharth KM, Kapur S, Ram CV. Angiotensin converting enzyme gene polymorphism and hypertension: no ace yet in the pack of cards. J Assoc Physicians India. 2012; 60:9-10.
  6. 6. Williams RR, Hunt SC, Hasstedt SJ, Hopkins PN, Wu LL, Berry TD, et al. Multigenic human hypertension: evidence for subtypes and hope for haplotypes. J Hy-pertens Suppl. 1990; 8(7):S39-46.
  7. 7. Dudley CR, Giuffra LA, Reeders ST. Identifying genetic determinants in human essential hypertension. J Am Soc Nephrol. 1992; 3(4 Suppl):S2-8.10.1681/ASN.V34s21457757
  8. 8. Kunes J, Zicha J. The interaction of genetic and environmental factors in the etiology of hypertension. Physiol Res. 2009; 58 Suppl 2:S33-41.10.33549/physiolres.93191320131935
  9. 9. Lind JM, Chiu CL. Genetic discoveries in hypertension: steps on the road to therapeutic translation. Heart. 2013; 99(22):1645-51. DOI: 10.1136/heartjnl-2012-30288310.1136/heartjnl-2012-30288323474626
  10. 10. Jiang X, Sheng H, Li J, Xun P, Cheng Y, Huang J, et al. Association between renin-angiotensin system gene polymorphism and essential hypertension: a community-based study. J Hum Hypertens. 2009; 23(3):176-81. DOI: 10.1038/jhh.2008.12310.1038/jhh.2008.12318830250
  11. 11. Zhao J, Qin X, Li S, Zeng Z. Association between the ACE I/D polymorphism and risk of ischemic stroke: an updated meta-analysis of 47,026 subjects from 105 case-control studies. J Neurol Sci. 2014; 345(1-2):37-47. DOI: 10.1016/j.jns.2014.07.02310.1016/j.jns.2014.07.02325082780
  12. 12. Niu W, Qi Y, Hou S, Zhai X, Zhou W, Qiu C. Haplotype-based association of the renin-angiotensin-al-dosterone system genes polymorphisms with essential hypertension among Han Chinese: the Fangshan study. J Hypertens. 2009; 27(7):1384-91. DOI: 10.1097/HJH.0b013e32832b7e0d10.1097/HJH.0b013e32832b7e0d19412130
  13. 13. Niu S, Zhang B, Zhang K, Zhu P, Li J, Sun Y, et al. Synergistic effects of gene polymorphisms of the renin-angiotensin-aldosterone system on essential hypertension in Kazakhs in Xinjiang. Clin Exp Hypertens. 2016; 38(1):63-70. DOI: 10.3109/10641963.2015.106098510.3109/10641963.2015.106098526305278
  14. 14. He SW, Huang HW, Tan SQ, Fu X, Su LL, Peng DX, et al. Influence of angiotensin-converting enzyme insertion/deletion polymorphism on nitric oxide production in hypertensives and hypercholesterolaemics. J Clin Pharm Ther. 2011; 36(2):187-93. DOI: 10.1111/j.13652710.2010.01176.x10.1111/j.13652710.2010.01176.x
  15. 15. Saab YB, Gard PR, Overall AD. The association of hypertension with renin-angiotensin system gene polymorphisms in the Lebanese population. J Renin Angiotensin Aldosterone Syst. 2011; 12(4):588-94. DOI: 10.1177/147032031140846510.1177/147032031140846521628354
  16. 16. Rajan S, Ramu P, Umamaheswaran G, Adithan C. Association of aldosterone synthase (CYP11B2 C-344T) gene polymorphism & susceptibility to essential hy-pertension in a south Indian Tamil population. Indian J Med Res. 2010; 132:379-85.
  17. 17. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr., et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003; 42(6):1206-52. DOI: 10.1161/01.HYP.0000107251.49515.c210.1161/01.HYP.0000107251.49515.c214656957
  18. 18. Urhan M, Degirmenci I, Harmanci E, Gunes HV, Metintas M, Basaran A. High frequency of DD poly-morphism of the angiotensin-converting enzyme gene in Turkish asthmatic patients. Allergy Asthma Proc. 2004; 25(4):243-7.
  19. 19. Hulyam K, Aysegul B, Veysi GH, Demet O, Irfan D, Ertugrul C, et al. Frequency of angiotensin II type 1 receptor gene polymorphism in Turkish acute stroke patients. J Cell Mol Med. 2013; 17(4):475-81. DOI: 10.1111/jcmm.1201710.1111/jcmm.12017382264823480670
  20. 20. Srivastava K, Chandra S, Bhatia J, Narang R, Salu-ja D. Association of angiotensinogen (M235T) gene polymorphism with blood pressure lowering response to angiotensin converting enzyme inhibitor (Enal-april). J Pharm Pharm Sci. 2012; 15(3):399-406. DOI: 10.18433/J3KW3B10.18433/J3KW3B22974788
  21. 21. Yu H, Zhang Y, Liu G. Relationship between polymorphism of the angiotensin-converting enzyme gene and the response to angiotensin-converting enzyme inhibition in hypertensive patients. Hypertens Res. 2003; 26(11):881-6. DOI: 10.1291/hypres.26.88110.1291/hypres.26.88114714579
  22. 22. Voors AA, van Geel PP, Oosterga M, Buikema H, van Veldhuisen DJ, van Gilst WH. Vascular effects of quinapril completely depend on ACE insertion/deletion polymorphism. J Renin Angiotensin Aldosterone Syst. 2004; 5(3):130-4. DOI: 10.3317/jraas.2004.02910.3317/jraas.2004.02915526248
  23. 23. Ramu P, Umamaheswaran G, Shewade DG, Swaminathan RP, Dutta TK, Balachander J, et al. Candidate Gene Polymorphisms of Renin Angiotensin System and Essential Hypertension in a South Indian Tamilian Population. International Journal of Human Genetics. 2011; 11(1):31-40. DOI: 10.1080/09723757.2011.1188612010.1080/09723757.2011.11886120
  24. 24. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990; 86(4):1343-6. DOI: 10.1172/JCI11484410.1172/JCI1148442968681976655
  25. 25. Gunes HV, Ata N, Degirmenci I, Basaran A, Timuralp B, Dikmen M, et al. Frequency of angiotensin-converting enzyme gene polymorphism in Turkish hypertensive patients. Int J Clin Pract. 2004; 58(9):838-43. DOI: 10.1111/j.1742-1241.2004.00206.x10.1111/j.1742-1241.2004.00206.x
  26. 26. Bleumink GS, Schut AF, Sturkenboom MC, van Duijn CM, Deckers JW, Hofman A, et al. Mortality in patients with hypertension on angiotensin-I converting enzyme (ACE)-inhibitor treatment is influenced by the ACE insertion/deletion polymorphism. Pharmacogenet Genomics. 2005; 15(2):75-81. DOI: 10.1097/01213011200502000-0000310.1097/01213011200502000-00003
  27. 27. Degirmenci I, Kebapci N, Basaran A, Efe B, Gunes HV, Akalin A, et al. Frequency of angiotensin-converting enzyme gene polymorphism in Turkish type 2 diabetic patients. Int J Clin Pract. 2005; 59(10):1137-42. DOI: 10.1111/j.1368-5031.2005.00586.x10.1111/j.1368-5031.2005.00586.x
  28. 28. Cosenso-Martin LN, Vaz-de-Melo RO, Pereira LR, Cesarino CB, Yugar-Toledo JC, Cipullo JP, et al. Angio-tensin-converting enzyme insertion/deletion polymor-phism, 24-h blood pressure profile and left ventricular hypertrophy in hypertensive individuals: a cross-sectional study. European Journal of Medical Research. 2015; 20(1):74. DOI: 10.1186/s40001-015-0166-910.1186/s40001-015-0166-9
  29. 29. Abbas S, Raza ST, Chandra A, Rizvi S, Ahmed F, Eba A, et al. Association of ACE, FABP2 and GST genes polymorphism with essential hypertension risk among a North Indian population. Ann Hum Biol. 2015; 42(5):461-9. DOI: 10.3109/03014460.2014.96820610.3109/03014460.2014.968206
  30. 30. Barley J, Blackwood A, Carter ND, Crews DE, Cruickshank JK, Jeffery S, et al. Angiotensin converting enzyme insertion/deletion polymorphism: association with ethnic origin. J Hypertens. 1994; 12(8):955-7. DOI: 10.1097/00004872-199408000-0001410.1097/00004872-199408000-00014
  31. 31. Foy CA, McCormack LJ, Knowler WC, Barrett JH, Catto A, Grant PJ. The angiotensin-I converting enzyme (ACE) gene I/D polymorphism and ACE levels in Pima Indians. J Med Genet. 1996; 33(4):336-7. DOI: 10.1136/jmg.33.4.33610.1136/jmg.33.4.336
  32. 32. Sagnella GA, Rothwell MJ, Onipinla AK, Wicks PD, Cook DG, Cappuccio FP. A population study of ethnic variations in the angiotensin-converting enzyme I/D polymorphism: relationships with gender, hypertension and impaired glucose metabolism. J Hypertens. 1999; 17(5):657-64. DOI: 10.1097/00004872-199917050-0000910.1097/00004872-199917050-00009
  33. 33. Yi L, Gu YH, Wang XL, An LZ, Xie XD, Shao W, et al. Association of ACE, ACE2 and UTS2 polymorphisms with essential hypertension in Han and Dongxiang populations from north-western China. J Int Med Res. 2006; 34(3):272-83. DOI: 10.1177/14732300060340030610.1177/147323000603400306
  34. 34. Zee RY, Lou YK, Griffiths LR, Morris BJ. Association of a polymorphism of the angiotensin I-converting enzyme gene with essential hypertension. Biochem Biophys Res Commun. 1992; 184(1):9-15. DOI: 10.1016/0006-291X(92)91150-O10.1016/0006-291X(92)91150-O
  35. 35. Zhang J, Zhao B, Gesongluobu, Sun Y, Wu Y, Pei W, et al. Angiotensin-converting enzyme gene insertion/deletion (I/D) polymorphism in hypertensive patients with different degrees of obstructive sleep apnea. Hypertens Res. 2000; 23(5):407-11. DOI: 10.1291/hypres.23.40710.1291/hypres.23.40711016793
  36. 36. Yoshida K, Ishigami T, Nakazawa I, Ohno A, Tamura K, Fukuoka M, et al. Association of essential hypertension in elderly Japanese with I/D polymorphism of the angiotensin-converting enzyme (ACE) gene. J Hum Genet. 2000; 45(5):294-8. DOI: 10.1007/s10038007001910.1007/s10038007001911043512
  37. 37. Thomas GN, Tomlinson B, Chan JC, Sanderson JE, Cockram CS, Critchley JA. Renin-angiotensin system gene polymorphisms, blood pressure, dyslipidemia, and diabetes in Hong Kong Chinese: a significant association of tne ACE insertion/deletion polymorphism with type 2 diabetes. Diabetes Care. 2001; 24(2):356-61. DOI: 10.2337/diacare.24.2.35610.2337/diacare.24.2.35611213892
  38. 38. Srivastava K, Sundriyal R, Meena PC, Bhatia J, Narang R, Saluja D. Association of angiotensin converting enzyme (insertion/deletion) gene polymorphism with essential hypertension in northern Indian subjects. Genet Test Mol Biomarkers. 2012; 16(3):174-7. DOI: 10.1089/gtmb.2011.015510.1089/gtmb.2011.015522103580
  39. 39. Yang YL, Mo YP, He YS, Yang F, Xu Y, Li CC, et al. Correlation between renin-angiotensin system gene polymorphisms and essential hypertension in the Chinese Yi ethnic group. J Renin Angiotensin Aldosterone Syst. 2015; 16(4):975-81. DOI: 10.1177/147032031559869710.1177/147032031559869726283679
  40. 40. Togănel R, Muntean I, Duicu C, Făgărăşan A, Gozar L, Bănescu C. The role of eNOS and AGT gene polymorphisms in secondary pulmonary arterial hypertension in Romanian children with congenital heart disease. Rev Romana Med Lab. 2013;21(3):267-74. DOI:10.2478/rrlm-2013-003110.2478/rrlm-2013-0031
  41. 41. Hu DC, Zhao XL, Shao JC, Wang W, Qian J, Chen AH, et al. Interaction of six candidate genes in essential hypertension. Genet Mol Res. 2014; 13(4):8385-95. DOI: 10.4238/2014.October.20.1410.4238/2014.October.20.1425366732
DOI: https://doi.org/10.2478/rrlm-2019-0011 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624
Language: English
Page range: 159 - 168
Submitted on: Sep 20, 2018
Accepted on: Jan 7, 2019
Published on: May 2, 2019
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year

© 2019 Abdullah Arpacı, Meral Urhan-Kucuk, Aysegul Bayramoglu, Halil İbrahim Guler, Hasret Ecevit, Arif Suner, Sevim Karakaş-Celik, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.